Restylane Kysse receives positive feedback

17 Jul 2020

Hyaluronic acid dermal filler Restylane Kysse, produced by global pharmaceutical company Galderma, received high subject and partner satisfaction, according to new phase 4 study results.

The phase 4 ‘Kissability’ study, conducted by Galderma, collected questionnaires sent to 56 subjects older than 21 who had been in a steady relationship for at least six months. Their partners also completed the study.

It evaluated a subject-assessed Global Aesthetic Improvement Scale eight weeks after the procedure, as well as photographic review of naturalness of expression, age and lip texture.

According to the survey, 98% of subjects reported they were satisfied with the ‘kissability’ of their lips, 96% of subjects found their lips had a natural look and 87% felt more attractive after the fillers.

The filler was approved by the FDA for lip augmentation and the correction of upper perioral rhytids in May this year.


Log-in to post a comment